Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
alpha-MSH | 3 | 2024 | 71 | 1.350 |
Why?
|
Fuchs' Endothelial Dystrophy | 2 | 2024 | 103 | 1.000 |
Why?
|
Endothelium, Corneal | 3 | 2024 | 215 | 0.870 |
Why?
|
Glaucoma Drainage Implants | 1 | 2023 | 107 | 0.790 |
Why?
|
Phacoemulsification | 1 | 2023 | 149 | 0.760 |
Why?
|
Glaucoma, Open-Angle | 1 | 2023 | 738 | 0.540 |
Why?
|
Corneal Transplantation | 3 | 2024 | 321 | 0.490 |
Why?
|
DNA Damage | 1 | 2024 | 2449 | 0.470 |
Why?
|
Glaucoma | 1 | 2023 | 1185 | 0.430 |
Why?
|
Oxidative Stress | 1 | 2024 | 3113 | 0.430 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 2 | 2022 | 112 | 0.350 |
Why?
|
Dry Eye Syndromes | 2 | 2024 | 387 | 0.340 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18253 | 0.330 |
Why?
|
Melanocortins | 1 | 2024 | 10 | 0.230 |
Why?
|
Substance P | 1 | 2024 | 335 | 0.220 |
Why?
|
Corneal Edema | 1 | 2023 | 47 | 0.210 |
Why?
|
Trabecular Meshwork | 1 | 2023 | 101 | 0.210 |
Why?
|
Explosions | 1 | 2023 | 108 | 0.210 |
Why?
|
Ophthalmic Solutions | 1 | 2023 | 313 | 0.190 |
Why?
|
Cornea | 3 | 2023 | 1333 | 0.190 |
Why?
|
Th17 Cells | 2 | 2024 | 794 | 0.190 |
Why?
|
Hydrogen Peroxide | 1 | 2024 | 730 | 0.180 |
Why?
|
Eye Injuries, Penetrating | 1 | 2022 | 124 | 0.180 |
Why?
|
Retinal Neoplasms | 1 | 2022 | 146 | 0.180 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2024 | 3080 | 0.180 |
Why?
|
Eye Injuries | 1 | 2023 | 227 | 0.180 |
Why?
|
Retinoblastoma | 1 | 2022 | 317 | 0.170 |
Why?
|
Ultraviolet Rays | 1 | 2024 | 1080 | 0.160 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22172 | 0.160 |
Why?
|
Uveitis | 1 | 2022 | 395 | 0.160 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6214 | 0.150 |
Why?
|
Immunologic Memory | 1 | 2024 | 1359 | 0.150 |
Why?
|
Intraocular Pressure | 1 | 2023 | 1294 | 0.140 |
Why?
|
Forkhead Transcription Factors | 1 | 2024 | 1616 | 0.140 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2023 | 1119 | 0.140 |
Why?
|
Corneal Diseases | 1 | 2022 | 542 | 0.140 |
Why?
|
Interleukin-6 | 1 | 2024 | 3208 | 0.120 |
Why?
|
Cost of Illness | 1 | 2023 | 1936 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 844 | 0.110 |
Why?
|
Cell Line | 2 | 2024 | 15601 | 0.110 |
Why?
|
Graft Survival | 1 | 2024 | 3820 | 0.110 |
Why?
|
Graft vs Host Disease | 1 | 2024 | 3029 | 0.090 |
Why?
|
Mice | 8 | 2024 | 81533 | 0.090 |
Why?
|
Graft Rejection | 1 | 2024 | 4446 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2022 | 2046 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2022 | 3415 | 0.080 |
Why?
|
Vitamin D | 1 | 2022 | 3303 | 0.080 |
Why?
|
Animals | 8 | 2024 | 168467 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2024 | 5672 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6770 | 0.060 |
Why?
|
Receptors, Melanocortin | 1 | 2024 | 23 | 0.060 |
Why?
|
Desiccation | 1 | 2024 | 78 | 0.060 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2024 | 134 | 0.060 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 2022 | 20 | 0.050 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2024 | 306 | 0.050 |
Why?
|
Tissue Preservation | 1 | 2023 | 174 | 0.050 |
Why?
|
Cytoprotection | 1 | 2023 | 200 | 0.050 |
Why?
|
Streptozocin | 1 | 2023 | 194 | 0.050 |
Why?
|
Mice, Inbred C3H | 1 | 2024 | 915 | 0.050 |
Why?
|
Descemet Membrane | 1 | 2022 | 71 | 0.050 |
Why?
|
Neutrophil Infiltration | 1 | 2023 | 390 | 0.050 |
Why?
|
Eyelids | 1 | 2023 | 278 | 0.050 |
Why?
|
Humans | 12 | 2024 | 761572 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2023 | 3548 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2023 | 964 | 0.040 |
Why?
|
Eye | 1 | 2022 | 712 | 0.040 |
Why?
|
Eye Diseases | 1 | 2024 | 653 | 0.040 |
Why?
|
Sex Distribution | 1 | 2023 | 2281 | 0.040 |
Why?
|
Cell Death | 1 | 2024 | 1679 | 0.040 |
Why?
|
Age Distribution | 1 | 2023 | 2880 | 0.040 |
Why?
|
Cicatrix | 1 | 2023 | 798 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2022 | 1380 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2024 | 2302 | 0.030 |
Why?
|
Bone Density Conservation Agents | 1 | 2022 | 795 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2022 | 1685 | 0.030 |
Why?
|
Monocytes | 1 | 2023 | 2570 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2023 | 80646 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2024 | 5869 | 0.030 |
Why?
|
Visual Acuity | 1 | 2022 | 2672 | 0.030 |
Why?
|
Wound Healing | 1 | 2023 | 2805 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2022 | 8528 | 0.020 |
Why?
|
Female | 6 | 2024 | 392686 | 0.020 |
Why?
|
Health Care Costs | 1 | 2023 | 3242 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3384 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9319 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2024 | 18965 | 0.020 |
Why?
|
Macrophages | 1 | 2023 | 5769 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15732 | 0.020 |
Why?
|
Male | 4 | 2024 | 360842 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10212 | 0.020 |
Why?
|
Inflammation | 1 | 2024 | 10773 | 0.010 |
Why?
|
Prognosis | 1 | 2022 | 29629 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29876 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13367 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 58986 | 0.010 |
Why?
|
United States | 1 | 2023 | 72335 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 64684 | 0.010 |
Why?
|
Child | 1 | 2022 | 80156 | 0.010 |
Why?
|
Aged | 1 | 2023 | 169310 | 0.010 |
Why?
|
Middle Aged | 1 | 2022 | 220920 | 0.000 |
Why?
|
Adult | 1 | 2022 | 221203 | 0.000 |
Why?
|
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_